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Annexins are a family of proteins that bind to phospholipids
in a calcium-dependent manner. Earlier studies implicated
annexin A6 (AnxA6) to inhibit secretion and participate in the
organization of the extracellular matrix. We recently showed
that elevatedAnxA6 levels significantly reduced secretion of the
extracellular matrix protein fibronectin (FN). Because FN is
directly linked to the ability of cells tomigrate, this prompted us
to investigate the role ofAnxA6 in cellmigration.Up-regulation
of AnxA6 in several cellmodels was associatedwith reduced cell
migration in wound healing, individual cell tracking and three-
dimensional migration/invasion assays. The reduced ability
of AnxA6-expressing cells to migrate was associated with
decreased cell surface expression of V3 and 51 integrins,
both FN receptors. Mechanistically, we found that elevated
AnxA6 levels interfered with syntaxin-6 (Stx6)-dependent recy-
cling of integrins to the cell surface. AnxA6 overexpression
caused mislocalization and accumulation of Stx6 and integrins
in recycling endosomes, whereas siRNA-mediated AnxA6
knockdown did not modify the trafficking of integrins. Given
our recent findings that inhibition of cholesterol export from
late endosomes (LEs) inhibits Stx6-dependent integrin recy-
cling and that elevated AnxA6 levels cause LE cholesterol accu-
mulation, we propose that AnxA6 and blockage of LE choles-
terol transport are critical for endosomal function required for
Stx6-mediated recycling of integrins in cell migration.
After initial evidence from our laboratory and others for a
role of the hepatic endocytic compartment in themodulation of
ECM6 (1), it is now well established that endosomes contribute
tomultiple aspects of cellmigration and invasion (2). This com-
plex and multifunctional process requires a plethora of mole-
cules along endo- and exocytic pathways, enabling the delivery
of ECM, integrins, and signaling proteins to the cell surface. To
orchestrate and coordinate this complexity, involvement of Rab
and solubleN-ethylmaleimide-sensitive factor attachment pro-
tein (SNAP) receptor (SNARE) proteins togetherwith cytoskel-
eton elements is well documented (3, 4). Furthermore, because
cellular movement requires dynamic reorganization of mem-
brane domains, lipids, in particular cholesterol, but also other
less well known proteins participate. In this study, we show that
a member of the annexin family, AnxA6, and most likely its
ability to impact cellular cholesterol transport and distribution,
regulate integrin cell surface expression and consequently cell
migration.
Annexins are evolutionarily conserved proteins that bind to
acidic phospholipids in a calcium-dependent manner and have
been described to regulate membrane trafficking events along
endo- and exocytic pathways (5). Several reports revealed links
between AnxA6 and various aspects of cell migration. First,
early studies identified AnxA6 as a potential receptor for
fetuin-A and chondroitin sulfate proteoglycans (6–8). Second,
we showed that membrane targeting of AnxA6 correlated with
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the stabilization of the cortical actin cytoskeleton (9). Third,
reduced AnxA6 expression appeared to contribute to breast
cancer progression by promoting the loss of functional cell-cell
and/or cell-ECMcontacts (10). Fourth, the scaffolding function
of AnxA6may alter the activity of receptors, such as the epider-
mal growth factor receptor (EGFR) and downstream effector
pathways, including the Ras/mitogen-activated protein kinase
(MAPK) signaling cascade, which are well known to contribute
to cancer cell motility and invasiveness (11–13). Finally, we
recently identified that elevated levels of AnxA6 cause a
Niemann-Pick type C1 (NPC1)-like phenotype, which is char-
acterized by an accumulation of cholesterol in LEs. This was
associated with reduced caveolin transport to the cell surface
but also mislocalization of several SNARE proteins, including
SNAP23 and Stx4 (14, 15). Both SNAP23 and Stx4 are normally
engaged in the delivery of secretory vesicles to the cell surface;
however, their mislocation upon AnxA6 overexpression inhib-
ited exocytic pathways, including FN secretion (15).
Cholesterol is considered indispensible for cell migration.
The activity of Rac/Rho GTPases, which drive cellular move-
ment, is sensitive to cholesterol levels and distribution in the
plasma membrane (16). Similarly, cholesterol depletion using
statins interferes with the invasivemorphology of breast cancer
cells (17). Recruitment of integrins to focal adhesions for cell
migration requires cholesterol (18, 19). Endocytosed LDL cho-
lesterol from LEs controls the formation of focal adhesions at
the leading edge of cells (20).Overall, dietary, genetic, and path-
ological changes in cholesterol metabolism seem to affect the
migratory behavior of cancer cells (21–23). Hence, we hypoth-
esized that AnxA6-induced alterations in the cellular distribu-
tion of cholesterol could be an additional mechanism affecting
cell motility.
The present study shows for the first time how elevation of
AnxA6 levels interferes with cell migration. Mechanistically,
this is caused by LE cholesterol accumulation in AnxA6-ex-
pressing cells, which leads to the mislocalization of Stx6, a
SNARE protein that is essential for the cell surface delivery of
integrins.
Experimental Procedures
Reagents and Antibodies—Nutrient mixture Ham’s F-12 and
DMEM were from Biological Industries. Hanks’ buffered salt
solution (HBSS) was from Gibco. FN, filipin, saponin, L-gluta-
thione, poly-L-lysine, protein G-Sepharose, U18666A, water-
soluble cholesterol, and iodoacetamide were from Sigma. Para-
formaldehyde was from Electron Microscopy Sciences, and
Mowiol was from Calbiochem. Sulfo-NHS-SS-biotin and
streptavidin beads were from Fisher Scientific. Polyclonal anti-
AnxA6 was prepared in our laboratory and has been described
elsewhere (24, 25). Polyclonal anti-human integrin 1 and
mouse IgG1 ( isotype) were from BioLegend. Monoclonal
anti-V, -5, and -3 integrins; anti-GM130; anti-Stx6; and rat
IgG2a ( isotype) were from BD Biosciences. Polyclonal
anti-V and monoclonal anti-5 (PB1) integrins were from
Millipore and the Developmental Studies Hybridoma Bank
(The University of Iowa), respectively. Monoclonal anti-actin
was fromMP Biomedicals, anti-transferrin receptor (Tf-R) and
horseradish peroxidase-conjugated secondary antibodies were
from Zymed Laboratories Inc. Polyclonal anti-VAMP3 (Cel-
lubrevin), anti-VAMP4, and anti-Vti1awere fromSynaptic Sys-
tems. Anti-cation-independentmannose 6-phosphate receptor
was fromAbcam.Alexa Fluor-conjugated secondary antibodies
were from Molecular Probes. Fluorescent cholera toxin B
(CTxB;A647-conjugated)was fromMolecular Probes. Fluores-
cent shiga toxin B (STxB) was kindly provided by Dr. Ludger
Johannes (Curie Institute, Paris, France). Fluorescent transfer-
rin (Tf-A488) was from Invitrogen. The enhanced green fluo-
rescent protein-tagged AnxA6 expression vector has been
described elsewhere (12, 14). Expression vectors encoding
NPC1-GFP andNPC1-P692S-GFPwere kindly provided byDr.
Matthew P. Scott (Stanford University, Stanford, CA).
Cell Culture, DNA Constructs, and Transfections—Chinese
hamster ovary wild-type cells (CHO-WT) and AnxA6-overex-
pressing CHO (CHO-A6) cells were grown in Ham’s F-12 with
10% fetal calf serum (FCS), 2 mM L-glutamine, 100 units/ml
penicillin, and 100g/ml streptomycin at 37 °C, 5%CO2.A431-
WT, AnxA6-overexpressing A431 (A431-A6), COS-1, HeLa,
HeLa-A6KD, and MDA-MB-231 cells were grown in DMEM
and supplements as above. The generation of stable CHO-A6
andA431-A6 cell lines and theHeLa cell linewith stableAnxA6
knockdown has been described in detail (15, 25). For transient
transfections, cells at 50% confluence were transfected with 0.8
g of DNA/ml using Effectene (Qiagen) or Lipofectamine-LTX
(Invitrogen) following the manufacturers’ instructions. For
Stx6, Stx4, and AnxA6 knockdown studies, cells (70% conflu-
ence) were transfected with siRNA (100 M) targeting mouse
Stx6 (5-GGAUUGUUUCAGAGAUGGAtt-3, 5-GGACCU-
CGAUGAAACCAUCtt-3, and 5-GGAUCAGAUGUCAGC-
UUCAtt-3) and Stx4 (5-GGAAGCUGAUGAGAAUUACtt-
3) (AmbionBioSciences) andhuman andmouseAnxA6 (Santa
Cruz Biotechnology, sc-29688 and sc-29689) with Lipo-
fectamine 2000 according to the manufacturer’s instructions.
Studies were conducted after 72 h. Scrambled siRNA served as
a negative control (5-GGAATCTCATTCGATGCATAC-3).
In some experiments, cells were treated with U18666A as
described previously (15, 24).
Immunoprecipitation—Cells were grown on 100-mm dishes,
washed with PBS, and solubilized in TGH buffer (1% Triton
X-100, 10% glycerol, 50 mMNaCl, 50 mMHEPES, pH 7.3, 1 mM
Na3VO4, 10 mM NaF, 1 mM PMSF, 10 mg/ml leupeptin, 10
mg/ml aprotinin) followed by centrifugation at 12,000  g for
10 min at 4 °C. Proteins from supernatants (500–800 g) were
incubated with 2 g of mouse monoclonal anti-Stx6, rabbit
polyclonal anti-VAMP4, or mouse/rabbit IgG for 2 h at 4 °C,
respectively, followed by an additional 60-min of incubation
upon addition of protein G-Sepharose. Immunoprecipitates
were washed twice in TGH containing 150 mM NaCl and once
in TGH without NaCl and analyzed for Stx6, VAMP3, Stx16,
VAMP4, and Vti1a (15).
Microscopic Techniques and Image Analysis—Cells were
grown on coverslips, fixed with 4% paraformaldehyde for 20
min, washed, permeabilized with 0.1% saponin for 10 min,
blocked with 1% BSA for 5 min, and incubated with primary
and secondary antibodies. Alternatively, cells were permeabi-
lized with 0.1% Triton X-100 for 5 min. In some experiments,
cells were seeded onto FN-coated coverslips; therefore cover-
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slips were washed twice with PBS, coated with poly-L-lysine (50
g/ml) in PBS for 2 h, washed twice with PBS, incubated in 20
g/ml FN for 3 h, and washed twice with PBS before use.
Finally, samples were mounted in Mowiol, and cells were
observed using a Leica DMI 6000B epifluorescence inverted
microscope equipped with an HCX PLA Apo 63 oil immer-
sion objective. Some images were captured with a Leica TCS
SP5 laser scanning confocal microscope equipped with a
DMI6000 inverted microscope, blue diode (405 nm), argon
(458/476/488/496/514 nm), diode-pumped solid state (561
nm), HeNe (594/633 nm) lasers, and Apo 63 oil immersion
objective lenses. Image analysis was performed with NIH
ImageJ software (26). Co-localization analysis was done using
the ICA (intensity correlation analysis) plug-in. To quantify
staining intensity, images were captured using identical micro-
scope settings.
Isolation of Subcellular Fractions—Subcellular fractionation
of CHO-WT and CHO-A6 membranes on discontinuous
sucrose gradients was performed, and the distribution of Stx6,
RE (VAMP3), trans-Golgi network (TGN)-Golgi (Golgin-97),
and plasma membrane markers (Na/K-ATPase) was ana-
lyzed. The cholesterol content (percentage of total cellular cho-
lesterol) of each fraction from both cell lines was determined
using the AmplexTM Red Cholesterol Assay kit (Molecular
Probes) according to the manufacturer’s instructions. Subcel-
lular fractionation procedures for the isolation of Golgi mem-
branes fromCHO cells have been described in detail previously
(27).
Biotinylation and Recycling Assays for Integrins—Cells were
washed in HBSS, incubated with sulfo-NHS-SS-biotin (0.15
mg/ml for 10 min), and then washed with HBSS, 5 mM Tris.
Cellswere lysed and centrifuged at 14,000 g for 20min at 4 °C.
Equal amounts of protein from the supernatant were incubated
for 1 h with streptavidin beads to precipitate biotinylated pro-
teins, which were analyzed by immunoblotting.
Integrin recyclingwasmeasured as described previously (28).
In brief, cell surface biotin-labeled cells were incubated for an
additional 30 min to allow internalization of surface biotiny-
lated proteins (quadruplicates for each cell line). One plate was
lysed, whereas the three other plates were washed twice in
HBSS followed by two washes in PBS, 0.5 mM EDTA. The
remaining surface biotin was removed by incubating cells with
reduced L-glutathione buffer (50 mM reduced L-glutathione, 75
mM NaCl, 2 mM EDTA, 75 mM NaOH, 0.1% BSA). Reduced
L-glutathione was neutralized with 10 mM iodoacetamide in
HBSS. Cells from a second plate were then lysed, and the
remaining two plates were incubated for 30 min in complete
cell culture medium. One plate was lysed, whereas the other
plate was incubated with reduced L-glutathione and iodoacet-
amide as described above to remove the surface biotin from
recycled proteins.
Multiscratch Assays—Multiscratch signaling assays were
performed as described (29). In brief, 5 105 cells were seeded
onto 6-well plates and grown to 90% confluence. Using a 200-l
pipette tip, five vertical and five horizontal scratches were
made, and lysates were prepared at 0, 30, and 60 min posts-
cratch. Cell lysates were analyzed byWestern blotting for total
and phosphorylated (Tyr(P)861) focal adhesion kinase (FAK)
and (Tyr(P)527) Src.
CTxB and STxB Uptake—Cells were incubated in DMEM,
10% FCS with fluorescently labeled CTxB and STxB (CTxB-
Cy5, 2 g/ml; STxB-Cy3, 1 g/ml) for 10 min at 37 °C. Non-
internalized CTxB and STxBwas removed, and cells were incu-
bated for an additional 5–60 min before fixation.
Internalization of5 Integrin—CHOcells were plated on FN-
coated coverslips (20 mg/ml) for 24 h followed by incubation
with 5 integrin antibody (PB1) (diluted 1:100 in complete
Ham’s F-12) for 1 h at 4 °C to allow the antibody to bind cell
surface 5 integrin. Then samples were washed with pre-
warmed medium and incubated for 1 h at 37 °C to allow inter-
nalization of antibody-labeled 5 integrin. Cells were washed
with PBS, fixed, and immunostained as described above.
Cell Tracking Assays—Cells were seeded on FN-coated plates
(10g/ml forA431 and 20g/ml forCHOcells).Migrationwas
monitored by time lapse video microscopy, and bright field
images were acquired at a rate of 10 min/frame for 14 h. Cell
migration (velocity) wasmeasured usingMtrackJ (ImageJ) (30).
Organotypic Invasion Assay—7.5  104/ml primary human
fibroblastswere embedded in three-dimensionalmatrices of rat
tail collagen type I. Rat tail tendon collagen solution was pre-
pared by the extraction of tendons with 0.5 M acetic acid (2
mg/ml). Detached, polymerized matrix (2.5 ml) in 35-mm
dishes was allowed to contract for 6 days in DMEM, 10% FCS
until fibroblasts had contracted the matrix to1.5-cm diame-
ter (31). Then 4 104A431-WTandA431-A6 cells were plated
on top of the matrix in complete medium and allowed to grow
to confluence for 5 days. The matrix was then mounted on a
metal grid and raised to the air/liquid interface, resulting in the
matrix being fed from below with complete medium that was
changed every 2 days. After 12 days, the cultures were fixed
using 4% paraformaldehyde and processed for hematoxylin and
eosin (H&E) staining. The invasion index was calculated as the
percentage of cells that invaded beyond30 m as a percent-
age of total cells in the assay.
Matrigel Migration/Invasion Assay—Cell invasion was ana-
lyzed using BD BioCoat Matrigel invasion chambers with
8-m-pore size polyethylene terephthalate membrane inserts
according to the manufacturer’s protocol (BD Biosciences).
Briefly, 6 104 cells per insert were seeded on the upper cham-
ber in serum-free medium. The lower chamber contained
DMEM supplemented with 10% FCS as chemoattractant. After
72 h at 37 °C, cells remaining in the upper chamber were
removed. Cells that had invaded the lower chamber were fixed
and stained with Diff-Quick stain (Lab Aids, Australia). As a
control, migration on uncoated inserts was determined. Images
were captured using a Nikon Eclipse TS100 microscope.
Wound Healing Assays—Six-well plates were marked with
horizontal lines at the base of the plate. 5  105 CHO-WT,
CHO-A6, A431-WT, and A431-A6 cells were seeded in tripli-
cate and grown until70% confluence. A scratch, using the tip
of a P10 pipette, was then made across the center of each well
such that the scratchwas perpendicular to themarked horizon-
tal lines. Images were acquired immediately after scratching
(t  0) and postscratch at t  4, 8, 12, 16, 24, 48, and 60 h,
respectively, until cells completely covered the scratched area.
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Cells were washed at each time point to remove possible cell
debris and non-adherent cells. Scratches were studied at 10
magnification using a Nikon Eclipse TS100 inverted micro-
scope, and images were collectedwith LeicaMicrosystemsDig-
ital Imaging. Image analysis was performed with ImageJ soft-
ware. The area of the scratchwas calculated for the various time
points as percent reduction in area over time. Three indepen-
dent experiments in triplicate per cell line were performed.
FlowCytometry—Cells were harvested in PBS, 0.5mMEDTA;
resuspended in ice-cold PBS, 1% FCS (FACS buffer); and incu-
bated in FACSbufferwith anti-integrins (0.01g/ml5 and3;
0.02g/ml V) for 1 h. Cells were washed, incubated with fluo-
rescently tagged secondary antibody for 1 h, and then washed
again. Cell surface fluorescence was measured using FACS-Can-
toII cytometer at 4 °C.
Statistics—Error bars depict standard deviation (S.D.). Statis-
tical significance was determined with GraphPad Prism by
unpaired Student’s t test or analysis of variance test as indicated
(*, p 0.05; **, p 0.01; ***, p 0.001).
Results
ElevatedAnxA6 Levels Reduce CellMigration and Invasion—
The reduced FN secretion in cells with high levels of AnxA6
(15) prompted us to examine cell migration. Two cell models
were mainly used in this study: A431 cells (A431-WT), which
lack endogenous AnxA6, and A431 cells stably overexpressing
AnxA6 (A431-A6) and CHO-WT versus CHO-A6, both
described extensively in previous studies (25, 32). AnxA6 levels
in the CHO-A6 and A431-A6 cell line are comparable with
endogenous AnxA6 levels in other commonly used epithelial
cell lines, such as NRK and HeLa (data not shown). In addition,
the calcium- and cholesterol-regulated distribution of endoge-
nous and ectopically expressed AnxA6 at the plasma mem-
brane and the endosomal compartment is comparable (11, 12,
15, 24, 25, 27), making these cell lines suitable for further
studies.
We first compared cell migration in wound healing assays. In
both cell lines stably overexpressingAnxA6,wound closurewas
significantly slower compared with their wild-type counter-
parts (Fig. 1,A andD; quantification inB and E). In addition, we
compared the movement of individual cells using time lapse
video microscopy and by manually marking the speed and
direction of individual cell migration tracks. In both A431 and
CHO cells stably expressing AnxA6, the velocity was signifi-
cantly lower compared with the controls (Fig. 1, C and F). In
A431-A6 cells, this also correlated with an increased direction-
ality index (distance/trajectory index) (data not shown).
Next, using Transwell Matrigel invasion chambers (see
“Experimental Procedures”), large numbers of A431-WT cells
migrating/invading toward a chemoattractant (FCS) were
observed (Fig. 1G). In contrast, A431-A6 cells exhibited
reduced migration and a dramatic decrease (7.3-fold) in their
capacity to invade (see also quantification in Fig. 1G).
To assess the invading properties of cells 	AnxA6 in an in
vivo like setting, we then compared invasiveness of A431-WT
and A431-A6 cells in three-dimensional organotypic matrices
that more closely recapitulate a tumor stromal environment
(31). A431-WT cells moved into organotypic matrices in con-
siderable numbers over a 12-day period (Fig. 1H, including
quantification on the right). By contrast and after normalization
to cell number, invasion of A431-A6 cells into the three-dimen-
sional organotypic matrices was significantly reduced by 50 	
3%.
As proof of concept, we comparedmigration and invasion in
HeLa, which express substantial amounts of AnxA6, and the
AnxA6-depleted HeLa cell line (HeLa-A6KD) (11). HeLa-
A6KD cells displayed  4-fold increased migration/invasion
and a 45–55% elevated invasion index compared with controls
(Fig. 1I). Finally, the MDA-MB-231 breast cancer cell line, a
well established model to examine aggressive metastatic cell
behavior, was analyzed. MDA-MB-231 express significant
amounts of AnxA6 (12), and AnxA6 depletion in MDA-MB-
231 cells using RNAi knockdown increased wound closure by
20% compared with controls (data not shown).
Finally, to correlate reducedmigration in A431-A6 cells with
cellular signaling, we analyzed the activity of key players in
integrin signaling and cell migration, FAK and Src kinase. FAK
and Src activation is complex with Src-mediated phosphoryla-
tion of FAK at tyrosine 861 (Tyr(P)861-FAK) being essential to
promote focal adhesion assembly (33). Increased Src activity
correlates with reduced phosphorylation of the autoinhibitory
Tyr527 residue (Tyr(P)527-Src) (34).
Multiscratchwound healing assays (29) were performed, and
cell lysates prepared at t  0, 30, and 60 min postscratch were
analyzed for Tyr(P)861-FAK and Tyr(P)527-Src phosphoryla-
tion. Although A431-WT cells displayed elevated Tyr(P)861-
FAK levels and reduced Tyr(P)527-Src levels postscratch, con-
sistent with the activation of the signaling machinery required
for cell migration during wound closure, A431-A6 cells showed
decreased Tyr(P)861-FAK and increased Tyr(P)527-Src (Fig. 1J),
which correlated with reduced motility and invasiveness in
migration/invasion assays (Fig. 1,A–C,G, andH). Thus,manip-
ulation of AnxA6 levels in different cell lines modulates migra-
tion and invasion, indicating a general role for AnxA6 levels in
this process.
Integrin Recycling Is Reduced in AnxA6-overexpressing
Cells—Recycling of integrins is crucial for cell migration (19,
35). Integrins consist of  and  subunits that bind ECM pro-
teins to regulate cell adhesion and migration (36). Consistent
with the reduced migratory ability of cells with up-regulated
AnxA6 levels (Fig. 1), flow cytometry identified the significant
diminution of cell surface V, 3, and 5 integrins in CHO-A6
cells, in particular in cells plated onto FN (Fig. 2A).
To substantiate these findings, cell surface expression of
biotinylated integrins was analyzed (Fig. 2B). In line with the
above studies, reduced cell surface expression of V (60.7 	
12.9%) and5 (78.2	 7.6%) integrinswas observed inCHO-A6
cells (Fig. 2B, lanes 1 and 2), whereas total integrin levels were
comparable in both cell lines (compare lanes 3 and 4).
In support of these findings, 5 integrin wasmainly localized
at the plasma membrane in CHO-WT (see arrowheads) but
accumulated in the perinuclear region of CHO-A6 cells (Fig.
2C). In line with Rab11 regulating 1 integrin recycling (37),
these intracellular pools of 5 co-localized with Rab11-GFP
and VAMP3 (see dashed squares and insets), suggesting that
reduced 5 integrin cell surface expression in AnxA6-express-
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FIGURE 1. AnxA6 overexpression reduces cell migration and invasion. A and D, wound closure of A431-WT (WT) and A431-A6 (A6) cells (A) and
CHO-WT and CHO-A6 cells (D). The relative percentage of wound closure was calculated (B and E). Data represent the mean 	 S.E. from three
independent experiments done in triplicate. Representative images of cell migration are shown. A431-WT and A431-A6 (C) and CHO-WT and CHO-A6
cells (F) were plated on FN, and movement of cells was recorded by time lapse video microscopy for 12 h. Individual cell migration tracks were marked,
and the speed (velocity) was recorded and quantified. G, Transwell migration and invasion of A431-WT and A431-A6 cells. Representative images from
two independent experiments with duplicate samples are shown. Migrating and invading cells from six fields per cell line were quantified, and relative
invasion was calculated. H, organotypic invasion assay with A431-WT and A431-A6 cells plated on three-dimensional matrices of rat tail collagen. Cells
were allowed to invade for 12 days, fixed, and processed for H&E staining. The invasion indexwas calculated as the percentage of total cells (14,506 cells)
that invaded beyond 30 m. Representative images of three independent experiments are shown. Scale bar, 10 m. I, Transwell migration and
invasion of HeLa and HeLa-A6KD cells. Representative images from two independent experiments with duplicate samples are shown. Migrating and
invading cells from six fields per cell line were quantified, and relative invasion was calculated. J, multiscratch signaling assays were performed as
described (29). Cell lysates were prepared at t 0, 30, and 60min postscratch and analyzed byWestern blotting for total and phosphorylated (Tyr(P)861)
FAK and (Tyr(P)527) Src as indicated. *, p 0.05; ***, p 0.001. Error bars shown in the figure represent S.E.
FIGURE 2.Reduced cell surface expressionof integrins inAnxA6-overexpressing cells.A, cell surface expression ofV,3, and5 integrins determinedby
flowcytometryofCHO-WT (WT) andCHO-A6 (A6) cells	FN. Valueswerenormalized toCHO-WT.B, total (lysates) and cell surfacebiotinylated (Strept PD)Vand
5 integrins from CHO-WT and CHO-A6 cells. C, co-localization of 5 integrin with Rab11-GFP and VAMP3 in CHO-WT and CHO-A6 cells. Arrowheads point to
5 integrin at the plasmamembrane in CHO-WT cells. Co-localization of Rab11-GFP, 5 integrin, and VAMP3 in CHO-A6 cells is indicated (see dashed square).
Scale bar, 10 m. D, V integrin recycling in CHO-WT (lanes 1–4) and CHO-A6 (lanes 5–8) cells. A shorter exposure of the same experiment is also shown.
Biotin-labeled V integrins at the cell surface (lanes 1 and 5), internalized after 30min (lanes 2 and 6) and total internalized-recycled pool (lanes 3 and 7) and in
the recycling compartment (lanes 4 and 8)werequantified (**,p0.01; two independent experiments). TotalV, AnxA6, and actin fromeach lysate are shown.
E, cell surface expression of V, 5, and 3 integrins determined by flow cytometry in A431-WT and A431-A6 cells. F, immunolabeling of 1 integrin with
VAMP3 inA431-WTandA431-A6cells.Arrowheadspoint to1 integrin/VAMP3co-localization in theperinuclear regionofA431-A6cells.Scale bar, 10m.*,p
0.05; ***, p 0.001. Error bars shown in the figure represent S.D.
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ing CHO cells was due to its accumulation in the RE
compartment.
Finally, we biotinylated the cell surface of CHO-WT and
CHO-A6 cells (Fig. 2D, lanes 1 and 5) followed by internaliza-
tion of biotin-labeled integrins for 30min. Then surface biotin-
labeled integrins were removed (lanes 2 and 6), and cells were
allowed to recycle the internal pool of biotinylated V integrin
(lanes 3 and 7) (28). Almost all V integrin reappeared at the
cell surface of CHO-WT cells (lane 8), whereas in CHO-A6
cells,20% of biotinylated V remained in the recycling com-
partment (lane 4). Hence, up-regulation of AnxA6 interferes
with V integrin recycling. Similarly, integrin surface expres-
sion was reduced (Fig. 2E), and 1 integrin accumulated in the
VAMP3-positive recycling compartment of A431-A6 cells (Fig.
2F).
Because3 integrin recycling to the cell surface involves traf-
ficking through the TGN in HeLa cells (38), we determined
whether5 integrin also recycles through theVAMP4-contain-
ing TGN compartment of CHO cells. Fig. 3A shows that a pop-
ulation of 5 integrin co-localizes with VAMP4 after 60 min of
antibody internalization in CHO-WT (see arrowheads) but not
in CHO-A6 cells. Thus, recycling trafficking routes of integrins
through TGN compartments appear disrupted upon elevation
of AnxA6 levels. Given the dose-dependent manner how
FIGURE 3. siRNA-mediated AnxA6 knockdown does not interfere with integrin trafficking in CHO and HeLa cells. A, endocytosed 5 integrin traffics to
the VAMP4 compartment in CHO-WT cells. Cell surface 5 integrin was tagged by incubation with a monoclonal antibody at 4 °C, and internalization was
stimulated at 37 °C for 60 min. Arrowheads point to integrin accumulation in the TGN (VAMP4; red) in CHO-WT cells; small white arrows point to 5 integrin in
the recycling compartment in CHO-A6 cells. B and C, HeLa (B) and CHO-WT cells (C) were analyzed for the cellular distribution of 5 integrin upon AnxA6
knockdown (siRNA A6). Scrambled non-targeting siRNA (siRNA NT) served as a control. In control and AnxA6-depleted cells, 5 integrin was mostly located at
the plasmamembrane (including adjacent and limitingmembranes; see arrows). Right panels in B and C showWestern blot analysis of AnxA6 expression and
actin as a control of loading. Scale bars, 10 m.
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AnxA6 interfered with integrin surface expression, we hypoth-
esized that AnxA6 depletion would not alter the cellular distri-
bution of integrins. Indeed, upon siRNA-mediated AnxA6
knockdown in HeLa (Fig. 3B) or CHO wild-type cells (Fig. 3C),
we did not observe any significant changes in cholesterol distri-
bution as judged by filipin staining (data not shown), and in line
with this observation, the membrane staining pattern of 5
integrin was comparable with siRNA non-targeting control
counterparts.
Stx6 Distribution in AnxA6-overexpressing Cells—We and
others have shown that recycling of endocytosed integrins,
such as V3 and 51, requires Stx6 and determines cell sur-
face integrin levels (28, 38–40). Therefore, we investigated
whether the overexpression of AnxA6 perturbed Stx6 expres-
sion and/or subcellular distribution.
Stx6 is mainly found in the TGN and shuttles to endocytic
compartments for TGN or post-Golgi trafficking events (41,
42). In CHO-WT cells, Stx6 was located in perinuclear TGN
structures and limited scattered vesicles with the majority of
Stx6-positive structures co-localizing with the Golgi marker
VAMP4 (Fig. 4A) (or TGN46; not shown). In contrast, in
CHO-A6 cells, Stx6 was predominantly observed in punctate
vesicular structures (see quantification of co-localization in Fig.
4A). A similar vesicular Stx6 staining was detected after tran-
sient AnxA6-GFP expression in CHO-WT (Fig. 4B). Similar
patterns of labeling were also observed in HeLa cells upon
ectopic GFP-AnxA6 expression (Fig. 4C) as well as in A431-A6
(not shown) but not in the siRNA AnxA6-depleted HeLa cells
(11) (Fig. 4D).
Then the distribution of Stx6 and compartment-specific
markers (VAMP3, Golgin-97, and Na/K-ATPase) in gradi-
ents designed to separate endosomes from plasma membrane
(Fig. 4E) was compared. The TGN and REs are not clearly sep-
arated in CHO cells (43), and consistent with the microscopy
(Fig. 4A), Stx6 was enriched in lighter membrane fractions
(fractions 6–8) in CHO-A6 cells, which contain high amounts
of RE marker (VAMP3). As shown previously (14), cholesterol
levels in Golgi and plasma membrane fractions (fractions
11–13) of CHO-A6 cells were reduced. Despite the drastic dis-
persion of Stx6 in vesicular structures, Golgi morphology was
not affected upon ectopic AnxA6 expression in CHO and A431
cells as evidenced by the comparable distribution of several
Golgi markers, such as galactosyltransferase-YFP, GM130, and
others (giantin and Stx16; data not shown), as well as the mor-
phological characterization of the Golgi apparatus by electron
microscopy (Fig. 4, F and G).
Stx6 has been identified in early endosomes (44), but very
little co-localization was observed between Stx6 and EEA1
(early endosomes), Rab4-GFP (early RE compartment), and
Rab7 andRab9 (LE) inCHOcells (data not shown).However, in
CHO-A6 cells, Stx6 clearly co-localized with RE markers
Rab11-GFP and VAMP3 (45) (Fig. 5A, see dashed squares and
arrowheads in enlarged insets and quantification of co-localiza-
tion in the right panel). The same redistribution of Stx6 was
observed in A431-A6 cells (Fig. 5B).
To assess whether Stx6mislocalization upon AnxA6 up-reg-
ulation would be associated with overall dysregulation of traf-
ficking at the Golgi-endosome interface, we examined retro-
grade transport. During retrograde transport, Stx6 shuttles
between the TGN and endocytic compartments (46) and inter-
nalization of CTxB and STxB was therefore analyzed as para-
digms for this pathway. CTxB internalization was similar in
COS-1 cells 	 AnxA6 (t  5 min), and CTxB accumulated in
the Golgi independently of AnxA6 overexpression (t 60min)
(Fig. 5C). Similarly, STxB was internalized and targeted to the
Golgi in HeLa cells overexpressing AnxA6 (Fig. 5D). Hence, the
retrograde pathway is not impaired in AnxA6-overexpressing
cells despite Stx6 missorting to REs. Also, the staining pattern
of cation-independent mannose 6-phosphate receptor, which
is transported through RE compartments, was similar in
CHO-WT and CHO-A6 cells (data not shown). As an addi-
tional control, we also analyzed the recycling of Tf and the
pattern ofTf-R inCHO-WTandCHO-A6 cells. In linewith our
previous data (25), alterations of Tf recycling kinetics were not
observed (data not shown).
Blockage of Cholesterol Export from LE Induces Relocation of
Stx6 to RE—Based on the LE cholesterol-sensitive localization
observed for several SNAREs, including Stx6, shown recently
(15, 40), we hypothesized that inhibition of cholesterol export
fromLE inAnxA6-overexpressing cells could selectively impair
the association of Stx6 with Golgi membranes and trigger Stx6
relocation to REs.
We therefore analyzed the localization of Stx6 in U18666A-
treated CHO-WT cells. U18666A is a lysosomotropic tertiary
amine that inhibits cholesterol export from LEs/lysosomes,
inducing LE cholesterol accumulation similar to NPC muta-
tions (47). Clearly, U18666A triggered the formation of filipin-
stained enlarged LEs, which in line with Fig. 6A did not co-lo-
calizewith Stx6. Furthermore, theTGNstaining pattern of Stx6
in CHO-WT was not apparent, indicating disassembly of Stx6
from the TGN to cytoplasmic vesicles upon U18666A treat-
ment. Similar findings were obtained from A431 cells (data not
shown). Indeed, in CHO-WT cells, Stx6 vesiculation was initi-
ated at 1 g/ml U18666A, whereas at 2 g/ml, Stx6 was almost
completely dispersed (Fig. 6B).
Consistent with Stx6 accumulating in REs, Stx6 levels were
reduced in purified Golgi fractions of CHO-A6 cells (Fig. 6C,
compare lanes 1 and 2). U18666A treatment strongly reduced
FIGURE 4. Localization of Stx6 in AnxA6-overexpressing cells. A, Stx6 and VAMP4 localization in CHO-WT and CHO-A6 cells. Enlarged areas show regions of
interest. Arrowheads point to co-localization of Stx6 in the TGN of CHO-WT cells. Arrows indicate scattered distribution of Stx6 staining in CHO-A6 cells.
Quantification of VAMP4/Stx6 co-localization is shown in the right panel. **, p 0.01. B, ectopic AnxA6-GFP expression induces vesicular Stx6 localization in
CHO-WT cells. Characterization of Stx6 localization in HeLa and HeLa-A6KD cells is shown. C, AnxA6-GFP and Stx6 (red) localization in HeLa cells. D, HeLa cells
were analyzed for the cellular distribution of Stx6 uponAnxA6 knockdown (siRNAA6). Scrambled non-targeting siRNA (siRNANT) served as a control. In control
and AnxA6-depleted cells, cellular distribution of Stx6 was comparable. E, subcellular fractionation of CHO-WT and CHO-A6 membranes on discontinuous
sucrosegradients.Distributionof Stx6, RE (VAMP3), TGN-Golgi (Golgin-97), andplasmamembranemarkers (Na/K-ATPase) is shown. The cholesterol content
(percentage of total cellular cholesterol) of each fraction fromboth cell lines is given. Characterization of the Golgi compartment in CHO-WT and CHO-A6 cells
is shown. F, galactosyltransferase-YFP and GM130 staining of CHO-WT and CHO-A6 cells is shown. G, ultrathin sections of CHO-WT, CHO-A6, A431-WT, and
A431-A6 cells were analyzed by electron microscopy. Scale bars, 10 m in B–D and 0.5 m in F. **, p 0.01. Error bars shown in the figure represent S.D.
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Golgi-associated Stx6 inCHO-WT (compare lanes 1 and 5) and
evenmore so in CHO-A6 cells (compare lanes 2 and 6), reflect-
ing a significant translocation of Stx6 away from theTGN.Cho-
lesterol levels in Golgi membranes from U18666A-treated
CHO-WT and CHO-A6 cells were comparable (Fig. 6E). Inter-
estingly, exogenous cholesterol only lanes 3 and 4), indicating
that different cholesterol pools and routes might determine the
association of Stx6 with the Golgi (quantification in Fig. 6D).
Stx6 interacts with several SNAREs, including VAMP3,
VAMP4, Stx16, and Stx4 (48). Therefore, Stx6 immunoprecipi-
tates from CHO-WT and CHO-A6 cells were compared and
analyzed for potential co-precipitation with different SNARE
partners. Although VAMP3, Vti1a, and Stx16 co-precipitated
with Stx6 to a similar extent in CHO-WT and CHO-A6 cells
(Fig. 6, F, G, and H), a significant decrease of Stx6/VAMP4-
containing SNARE complexes in CHO-A6 cells was observed
(Fig. 6, F and the reciprocal immunoprecipitate in G). Co-im-
munoprecipitation of Stx6with VAMP2, Stx10, or Stx4was not
detected (data not shown). Decreased co-localization of
VAMP4/Stx6 in CHO-A6 cells supported these findings (Fig.
4A). Importantly, decreased amounts of Stx6-VAMP4 com-
plexes were also observed in U18666A-treated CHO-WT cells
(Fig. 6J).
AnxA6 induced changes in SNAP23/Stx4 localization with-
out affecting their interaction partners Stx3, VAMP2, VAMP3,
andVAMP8 (15). Similarly, expression levels of Stx16, VAMP4,
and Vti1a, all SNARE partners of Stx6 in TGN-related endo-
cytic pathways, were comparable in CHO-WT and CHO-A6
cells (Fig. 6I).
To investigate whether loss of Stx6 would correlate with
reduced cell surface expression of V and 5 integrins in con-
trols, we silenced Stx6 in CHO-WT cells. These experiments
clearly demonstrated Stx6-dependent integrin cell surface
expression as V and 5 cell surface levels were significantly
reduced to 65	 5 and 20	 2.2%, respectively (Fig. 7A, compare
lanes 3 and 4). Up-regulatedAnxA6 levels also trigger SNAP23/
Stx4 mislocalization (15), and Stx4 can modulate integrin cell
surface expression (49). Therefore, we addressed whether Stx4
knockdown in CHO-WT would reduce cell surface integrins.
However, 50 	 8% knockdown of Stx4 depletion did not
decrease the surface expression of V or 5 integrin (Fig. 7A,
compare lanes 2 and 4). Hence, loss of Stx6 in CHO-WT trig-
gered a phenotype comparable with that of the CHO-A6 cell
line, strongly indicating that AnxA6 acts through Stx6 as part of
the machinery determining cell surface integrin delivery.
In addition, to examinewhether reduced integrin cell surface
expression could be due to deregulated distribution of choles-
terol in CHO-A6 cells; cells were plated onto FN; treated with
exogenous cholesterol; surface-immunolabeled with antibod-
ies against 5, V, and 3 integrins; and analyzed by flow
cytometry (Fig. 7B). As shown above (Fig. 7A; see also Fig. 2),
CHO-A6 cells consistently showed reduced cell surface expres-
sion of all three integrins. Most remarkably, addition of choles-
terol increased cell surface expression of these integrins by
10–20% inCHO-WTcells and evenmore (20–25% for5) in
CHO-A6 cells. However, incomplete recovery in cholesterol-
treatedCHO-A6 cells suggests additionalmechanisms contrib-
uting to reduced cell surface integrin expression in these cells.
Finally, to examine whether normalization of cholesterol
transport via NPC1 overexpression could rescue AnxA6-medi-
ated inhibition of integrin cell surface expression, NPC1-GFP
was ectopically expressed in CHO-A6 cells, and cell surface
integrins were analyzed by flow cytometry (Fig. 7C) and immu-
nocytochemistry (Fig. 7D). NPC1-GFPoverexpression restored
integrin cell surface expression by 41.6	 10.2 (5), 50.4	 2.8
(V), and 49.4 	 13% (3) (Fig. 7C). Moreover, NPC1 overex-
pression robustly reduced the perinuclear accumulation of 5
integrin, which corresponds to the RE compartment (co-local-
ized with transferrin receptor) (Fig. 7D), further reinforcing the
involvement of LE cholesterol for integrin cell surface expres-
sion. In addition, transient overexpression of a loss-of-function
NPC1mutant that cannot bind cholesterol, NPC1-P692S-GFP,
in CHO-WT cells reduced cell surface expression of 5, V,
and 3 integrins (Fig. 7C). This cholesterol-dependent impair-
ment of integrin delivery to the cell surface seemed to be highly
selective because constitutive recycling of other membrane
proteins upon AnxA6 expression was not disturbed (e.g. Tf-R
and EGFR; data not shown). Taken together, our data suggest
that inhibition of LE cholesterol export, driven by AnxA6 over-
expression, causes reduced cell surface integrin expression via
Stx6 mislocalization, which impairs fundamental aspects rele-
vant for cellmotility, such as cellmigration and invasion in both
two- and three-dimensional environments.
Discussion
This study shows that elevated AnxA6 levels triggers Stx6
mislocalization to REs, which is responsible for reduced integ-
rin recycling to the cell surface. Perturbed cholesterol distribu-
tion upon AnxA6 up-regulation and our recent studies from
NPC1 mutant cells (40) showing that LE cholesterol is critical
for Stx6-dependent integrin recycling suggest that elevated
AnxA6 levels interfere with integrin trafficking through
impaired LE cholesterol export. In support of this hypothesis,
ectopic expression of NPC1 restores cell surface integrin
expression in cells with high AnxA6 levels. These findings cor-
relate with decreased cell migration and invasion in AnxA6-
expressing cells, suggesting that AnxA6-dependent regulation
of LE cholesterol distribution impacts cell behavior.
AnxA6, through LE Cholesterol Pathways, Selectively Alters
the Location and Function of Stx6—Cholesterol is crucial for
membrane biogenesis but also adhesion, trafficking, and signal
transduction, all relevant for cell migration and invasion. Cer-
tainly, impaired availability of cholesterol through inhibition of
FIGURE 5. A, characterization of Stx6 localization in AnxA6-overexpressing cells. CHO-WT and CHO-A6 cells were transfected with Rab11-GFP and stained for
Stx6 and VAMP3. Enlarged areas show regions of interest. Arrowheads indicate co-localization of Stx6with Rab11 and VAMP3 in CHO-A6 but not CHO-WT cells.
Quantification of co-localization between Stx6/Rab11 and Stx6/VAMP3 is shown in the right panel. *, p 0.05; **, p 0.01. B, same as A but in A431-WT and
A431-A6 cells. Scale bars, 10mand2m inpanels enlarged areas, respectively. Retrograde transport is not affected in cells expressing elevatedAnxA6 levels.
Internalization of CTxB in COS-1 (C) and STxB in HeLa cells (D) transfected with AnxA6-GFP after 5 min, 20 min, and 1 h is shown. The Golgi was labeled with
anti-GM130. Scale bars, 5m. Insets show details of the Golgi area in transfected (1) and non-transfected (2) cells. Error bars shown in the figure represent S.D.
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FIGURE 6.Accumulationof LE cholesterol reduces the associationof Stx6with the TGN.A and B, CHO-WT andCHO-A6 cells treatedwith 3g/mlU18666A
(A) or 0–4.5g/ml U18666A for 16 h (B) were stainedwith anti-Stx6 and filipin. Insets show Stx6 staining details of the Golgi area. Scale bars, 10m. C–E, Golgi
membranes from CHO-WT and CHO-A6 cells 	cholesterol (chol) or 	U18666A were isolated. GM130 (Golgi marker), Stx6, and cholesterol (E) levels were
determined (for Stx6 quantification in Golgi membranes see D). GM130, Stx6, actin, and AnxA6 levels in cell lysates are shown. Characterization of Stx6-
containing SNARE complexes in CHO-WT andCHO-A6 cells is shown. Stx6 (F andH), Vti1a (G), VAMP4 (F andG), and control immunoprecipitateswere analyzed
for co-immunoprecipitation (IP) of VAMP3, Stx16, and VAMP4 (F and H) and Stx6 (G and H), respectively. Immunoprecipitated Stx6 is shown (black arrow in F).
H, quantification of Stx6 and VAMP4 co-precipitations (from F andG). I, Stx6, VAMP3, VAMP4, Stx16, Vti1a, and actin levels in CHO-WT (WT) and CHO-A6 (A6) in
input lysates are comparable. J, VAMP4 immunoprecipitates fromCHO-WTandCHO-A6cells	U18666Awereanalyzed for Stx6 co-immunoprecipitation. Input
lysates are shown in K. NRS, normal rabbit serum; NS, nonspecific (white arrow). *, p 0.05. Error bars shown in the figure represent S.D.
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cholesterol synthesis or delivery can affect processes associated
with human disease (50).
Vesicular and non-vesicular pathways to export cholesterol
fromLEs are central for cholesterol trafficking and homeostasis
(51, 52). Two annexins, AnxA2 and AnxA6, participate in cho-
lesterol transport through endocytic circuits. In early endo-
somes, the interplay of AnxA2 with cholesterol regulates bio-
genesis of multivesicular transport intermediates destined for
LEs (53). In LEs, AnxA6blocks the exit of cholesterol causing an
NPC-like phenotype (14, 54). AnxA6 appears to interfere with
NPC function because NPC1 overexpression diminished LE
cholesterol accumulation and restored trafficking and cellular
distribution of caveolin-1 (14) and SNAP23/Stx4 (15).
Here we show that AnxA6, through LE cholesterol pathways,
determinesTGNassociation and functioning of Stx6. U18666A
treatment or expression of loss-of-function NPC1 mutant in
CHO-WT cells also caused disintegration of TGN-associated
Stx6. Transient NPC1 expression restored the predominant
localization of Stx6 in TGN membranes of CHO-A6 cells. We
hypothesize that the reduction of cholesterol in Golgi mem-
branes due to blockage of LE cholesterol egress, observed here
and previously (14), together with the reduced formation of
Stx6-VAMP4 complexes could explain the retention of Stx6 in
the REs. Stx6 knockdown in HeLa cells (55) inhibits retrograde
transport, but despite Stx6 mislocalization in CHO-A6 cells,
certain pools of Stx6 proteins might still engage normally in
multiple other functions in these cells as SNARE complexes
with Stx16 and VAMP3 exist and retrograde transport of shiga
and cholera toxins to the Golgi was not affected (56). Missort-
ing of Stx6 in REs also did not compromise cation-independent
mannose 6-phosphate receptor trafficking in CHO-A6 cells.
However, AnxA6-induced accumulation of Stx6 in the
Rab11/VAMP3-positive RE compartment interfered with the
recycling of V3 and 51 integrins back to the cell surface,
FIGURE 7. A, total (lysates) and cell surface biotinylated (Strept PD) V and 5 integrins from CHO-WT expressing siRNA targeting Stx4 (lane 2) and Stx6 (lane 3)
and scrambled siRNA (scr; lane 1) aswell as non-transfected CHO-WT (WT) and CHO-A6 (A6) cells (lanes 4 and 5). B, exogenous cholesterol restores the recycling
of integrins. Cell surface expression of 5, V, and 3 integrins in CHO-WT and CHO-A6 cells plated on FN and treated	exogenous cholesterol (30g/ml for
90min). C, cell surface expression of5,V, and3 integrins in CHO-WT andCHO-A6 cells expressing control vector (GFP), NPC1-GFP, or NPC1-P692S-GFPwas
determinedby flowcytometry. Valueswerenormalized toCHO-WT.D, CHO-WTandCHO-A6 cellswere transfectedwithNPC1-GFPand stainedwith antibodies
for 5 integrin (red) and Tf-R (blue). Arrows indicate perinuclear accumulation of 5 integrin in CHO-A6 (or Tf-R in CHO-WT) cells that is lacking in the
NPC1-GFP-transfected cells. Scale bar, 10 m. *, p 0.05; **, p 0.01; ***, p 0.001. Error bars shown in the figure represent S.D.
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supporting other studies (38, 39). This can be mimicked by
depletion of Stx6 but not Stx4, suggesting that AnxA6-medi-
ated changes in cellular cholesterol distribution specifically
interfere with some but not all functions of Stx6. In line with
these findings, breast cancer MDA-MB-436 cells with high
endogenous AnxA6 levels (14) secrete much less TNF, which
requires Stx6 (48), compared withMDA-MB-468 with low lev-
els of endogenous AnxA6 (15).
The underlying mechanisms that enable cholesterol to regu-
late Stx6 localization in the TGN remain unclear. Cholesterol
depletion in the Golgi due to limited LE cholesterol supply
likely results in concomitant changes of the lipid environment
in TGN microdomains (57). This may interfere with Stx6-
VAMP4 complex formation and the interaction of Stx6 with
resident Golgi proteins, possibly in specialized cholesterol-rich
domains, forcing Stx6 trafficking along secretory pathways to
other compartments that provide Stx6 interaction partners.
Stx6-dependent Trafficking of Integrins Is Coordinated by
AnxA6andCholesterol—AnxA6-mediated cholesterol diminu-
tion in Golgi membranes significantly reduced FN secretion
(15). Also, in hepatocytes, which contain large amounts of
AnxA6 in endosomes (58), the level of ECM proteins (FN and
laminin) correlates with the cell surface expression of their cog-
nate integrins or adhesionmolecules (59, 60). Actually, we pro-
vided the first evidence for the hepatic endocytic compartment
modulating the ECM (1). As outlined above, this coincides with
Stx6-dependent trafficking of FN receptors V3 and 51
integrins (38, 39, 61, 62).
Several studies have associated the localization and function
of Stx6with cholesterol. Similar to theAnxA6-induced changes
in caveolin distribution and transport (14), silencing of Stx6
reduced the number of caveolae (42). Furthermore, Stx6 con-
tributes to the functioning of specialized microdomains and
focal adhesion sites that contain 51 integrin and FAK to par-
ticipate in the directional migration toward FN (39). Possibly
not directly related to Stx6 establishing cholesterol-rich
domains at the plasma membrane, Stx6 has been associated
with LDL cholesterol transport from LEs to the endoplasmic
reticulum via the TGN (63). Our previous study (14) and the
data shown here link AnxA6 and inhibition of LE cholesterol
egress with Stx6 missorting, which consequently affects cell
surface localization and recycling dynamics of the FN receptors
V3 and 51 integrins.
The role of cholesterol for integrin function is still poorly
understood. Cholesterol participates in the formation of signal-
ing complexes containing V3, CD47, and G-proteins (64)
and controls cell adhesion and migration onto FN (18). This
possibly requires Rab11, which modulates cholesterol trans-
port and homeostasis (65) and facilitates recycling of 1 integ-
rin (37).
Results presented here and previously suggest that the
AnxA6-induced cholesterol imbalance impairs integrin recy-
cling in two compartments. (i) Depletion of cholesterol at the
plasma membrane increased SNAP23- and Stx4-containing
SNARE complexes in the Golgi, consequently reducing their
availability as docking/fusion sites at the plasma membrane
(15). (ii) Reduced Stx6-VAMP4 complex formation in the TGN
caused Stx6 missorting/accumulation in REs.
AnxA6 and Cell Migration—AnxA6 binds to phospholipids,
actin, and signaling proteins, which is likely important for cell
adhesion and migration. The scaffolding/targeting function of
AnxA6 for the GTPase-activating protein p120GAP and pro-
tein kinase C, both negative regulators of the EGFR/Ras/
MAPK pathway, probably contributes to reduce migration/in-
vasion of AnxA6-expressing cells (9, 11, 12, 66). In fact, A431
cells express mutant p53, which drives invasion through con-
stitutive activation of both EGFR and integrin recycling and
signaling. Accordingly, inhibiting either EGFR or 5 integrin
significantly impeded A431 cell invasion (35). As AnxA6 inhib-
its EGFR in A431 cells (11, 25) and reduces integrin recycling,
the cooperative involvement of both AnxA6 properties could
decrease two- and three-dimensional invasion of AnxA6-ex-
pressing A431 cells. Data shown here also implicate AnxA6-
induced rearrangements of the actin cytoskeleton to contribute
to the reduced ability of AnxA6-expressing cells to migrate and
invade. AnxA6/actin interactions are mainly based on in vitro
studies, but we showed that constitutive membrane localiza-
tion of AnxA6 caused rearrangement and accumulation of
F-actin at the plasmamembrane (9). Recently, the first evidence
from live cells overexpressing AnxA6 supports a model of
AnxA6 as an organizer of membrane microdomains and the
underlying cytoskeleton (4). Future studies will have to clarify
the molecular mechanisms that enable AnxA6 to link cellular
cholesterol distribution with actin dynamics in cellular events
driving cell migration and invasion.
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